-
Posted by
Two Blokes Jul 16 -
Filed in
Stock
-
2 views
Hemogenyx Pharmaceuticals Awarded G-Rex\u00ae Grant to Support Scalable, Cost-Optimized CAR-T Manufacturing LONDON, UK / ACCESS Newswire / July 16, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has been awarded a $120,000 G-Rex\u00ae grant from ScaleReady, in collaboration with Wilson Wolf Manufacturing and Cell Ready (the "Grant"), to support the optimization and scale-up of the manufacturing process for its lead CAR-T product candidate, HG-CT-1, currently in a Phase I clinical trial for relapsed/refractory acute myeloid leukemia (R/R AML) in adults. The Grant will enable the Company to further develop a closed-system, G-Rex\u00ae-based, manufacturing platform, which is expected to reduce production complexity, streamline regulatory compliance, and significantly lower per-patient manufacturing costs.
